We are pleased to invite all researchers, PhD candidates, and students to an open lecture by Professor Dipanjan Chowdhury, PhD, titled “DNA repair and cell cycle: implications in cancer biology.” Professor Chowdhury is our long-standing collaborator from Harvard Medical School and the Dana-Farber Cancer Institute. More details about the lecture are available here.

We are pleased to announce that Barbara Pernak, a third-year student of medicine, has just started the Individual Course of Study. The program of the two-year study that she will carry out during ITS was rated the highest among all this year’s projects. As part of her scientific work, she will conduct a study entitled […]

We are pleased to announce that our long-term collaborator, Prof. Dipanjan Chowdhury, has been selected as the first incumbent of the Svanberg Family Chair within the Endowed Chairs program at Dana-Farber Cancer Institute. This distinction honors a distinguished senior faculty member and provides invaluable financial support in perpetuity to pursue research and care initiatives leading […]

We are thrilled to share the exciting news that Professor Wojciech Fendler, the Head of our Department, has been elected as the President of the Polish Medical Research Agency. This prestigious position recognizes Professor Fendler’s significant contributions to medical field, and his leadership within the academic community. For further details on the appointment, click here […]

We are excited to announce the release of book in collaboration with our Department, “Clinical Trials: Practice, Law, Ethics.” This comprehensive book offers a wide range of specific information and interdisciplinary knowledge pertinent to the conduct of clinical trials. It covers topics from the history of bioethical issues to strictly operational matters, and delves into […]

Dr. Konrad Stawiski has been elected as a member of the international working group focusing on artificial intelligence in oncological radiotherapy within the European Society for Radiotherapy and Oncology. Dr. Konrad Stawiski’s term will last for 3 years. The task of the working groups is to assist in developing clinical and technical guidelines, provide advice […]